Skip to content

Protein kinase inhibitors for acute leukemia

Citations of this article
Mendeley users who have this article in their library.

This artice is free to access.


Conventional treatments for acute leukemia include chemotherapy, radiation therapy, and intensive combined treatments (including bone marrow transplantor stem cell transplants). Novel treatment approaches are in active development. Recently, protein kinase inhibitors are on clinical trials and offer hope as new drugs for acute leukemia treatment. This review will provide a brief summary of the protein kinase inhibitors in clinical applications for acute leukemia treatment.




Ling, Y., Xie, Q., Zhang, Z., & Zhang, H. (2018, February 13). Protein kinase inhibitors for acute leukemia. Biomarker Research. BioMed Central Ltd.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free